Skip to content

Effect of Acute Physical Exercise on Memory

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04680494
Acronym
SPEMO
Enrollment
25
Registered
2020-12-23
Start date
2015-10-09
Completion date
2016-07-27
Last updated
2020-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Physical Exercise

Keywords

fMRI, BDNF, endocannabinoid, physical exercise

Brief summary

An increasing amount of studies show the beneficial effect of regular exercise on cognitive and brain functions and especially in the memory domain. Yet little is known of what happens within an acute bout of exercise and whether it would also yield cognitive effects. The literature clearly shows that molecules such as brain derived neurotrophic factor (BDNF) and endocannabinoids (mainly anandamide, AEA) are heavily involved in neural plasticity mechanisms and increase when we exercise hinting at possible mechanisms underlying memory improvement after exercise. This protocol assesses the effects of acute exercise on associative and motor sequence memory, their underlying neural activations (measured using fMRI) and blood biomarkers (BDNF and AEA). A related aim is to assess the effect of exercise intensity, therefore three exercising conditions (rest, moderate intensity and high intensity) were included. Finally, a 3-month delayed retest visit is also realized to assess effects of acute exercise on long-term memory consolidation.

Interventions

OTHERmoderate intensity physical exercise
OTHERhigh intensity physical exercise
OTHERrest

Sponsors

University Hospital, Geneva
CollaboratorOTHER
University of Geneva, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

This is a within-subject study, all participants perform all conditions in cross-over randomized order.

Eligibility

Sex/Gender
MALE
Age
18 Years to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * Right-handed, * Exercising regularly (at least twice per week). * VO2max comprised between 40ml/kg/min and 65ml/kg/min.

Exclusion criteria

\- Psychiatric and neurological history

Design outcomes

Primary

MeasureTime frameDescription
cognitive measures - performanceTill the end of the study for each participant, i.e.3 months (long time retest)we measure performance during cognitive tasks. Performance is measured as percentage of correct trials, with higher percentages corresponding to better performance - measured in percentages.
cognitive measures - reaction timesTill the end of the study for each participant, i.e.3 months (long time retest)we measure reaction times during cognitive tasks. For reaction times, lower measures correspond to faster response times and therefore to better outcome - measured in milliseconds.
BDNF levelsup to 1 hourwe measure BDNF levels before and after physical exercise and rest, measured in ng/mL of serum.
endocannabinoid levelsup to 1 hourwe measure endocannabinoid levels before and after physical exercise and rest, measured in ng/mL of plasma.
brain activationsup to 1 hourwe measure brain activations using fMRI during cognitive tasks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026